CardioGenics Holdings (CardioGenics Holdings) Change In Receivables : $-0.00 Mil (TTM As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Change In Receivables?

CardioGenics Holdings's change in receivables for the quarter that ended in Jan. 2016 was $-0.00 Mil. It means CardioGenics Holdings's Accounts Receivable increased by $0.00 Mil from Oct. 2015 to Jan. 2016 .

CardioGenics Holdings's change in receivables for the fiscal year that ended in Oct. 2015 was $0.00 Mil. It means CardioGenics Holdings's Accounts Receivable stayed the same from Oct. 2014 to Oct. 2015 .

CardioGenics Holdings's Accounts Receivable for the quarter that ended in Jan. 2016 was $0.38 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CardioGenics Holdings's liquidation value for the three months ended in Jan. 2016 was $-2.06 Mil.

CardioGenics Holdings Change In Receivables Historical Data

The historical data trend for CardioGenics Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Change In Receivables Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Change In Receivables

Get a 7-Day Free Trial

0.06

0.11

0.06

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

CardioGenics Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

CardioGenics Holdings (OTCPK:CGNH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CardioGenics Holdings's Days Sales Outstanding for the quarter that ended in Jan. 2016 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.38	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, CardioGenics Holdings's accounts receivable are only considered to be worth 75% of book value:

CardioGenics Holdings's liquidation value for the quarter that ended in Jan. 2016 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	2.345	+	0.75 * 0.38	+	0.5 * 0
=	-2.06

CardioGenics Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines